Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Rowland J. Bright-Thomas"'
Autor:
Norman van Rhijn, James Coleman, Lisa Collier, Caroline Moore, Malcolm D. Richardson, Rowland J. Bright-Thomas, Andrew M. Jones
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
BackgroundCystic fibrosis is an inherited disease that predisposes to progressive lung damage. Cystic fibrosis patients are particularly prone to developing pulmonary infections. Fungal species are commonly isolated in lower airway samples from patie
Externí odkaz:
https://doaj.org/article/199cce51ff77495e9a0b12ed675a7288
Publikováno v:
Journal of Cystic Fibrosis. 22:256-262
Publikováno v:
Journal of Cystic Fibrosis. 20:e40-e45
Background Non-invasive ventilation (NIV) is an established treatment option for cystic fibrosis (CF) patients with type 2 respiratory failure but the benefits of this therapy remain unclear. This study examined the long-term outcomes and response to
Publikováno v:
Frontiers in Transplantation. 1
Cystic fibrosis (CF) is a multisystem disorder and represents the most common inherited condition leading to death in Western countries. Previous reports of chronic kidney disease (CKD) in CF focus on cases post lung, or other solid organ, transplant
Publikováno v:
British Journal of Hospital Medicine. 82:1-3
Autor:
Andrew Jones, Rowland J. Bright-Thomas, Emma A Davies, Jordan B Dennis, Andrew Turner, Lisa Collier, William Welfare, Peter J. Barry
Publikováno v:
Journal of Cystic Fibrosis. 19:808-814
Introduction An outbreak of Influenza B occurred at a large United Kingdom (UK) regional adult cystic fibrosis (CF) centre in May 2016. This was late in the UK 2015–2016 influenza season and occurred on a specialist ward with strict infection contr
Autor:
Javaid Iqbal, Karuna Sapru, Rowland J. Bright-Thomas, Dipesh H. Vasant, Peter J. Barry, Andrew M. Jones, John Walmsley
Publikováno v:
Posters – highly commended.
Publikováno v:
Pearmain, L, Gupta, R & Bright-Thomas, RJ 2020, ' Lessons of the month 1: Salbutamol induced lactic acidosis: clinically recognised but often forgotten. ', Clinical medicine (London, England) . https://doi.org/10.7861/clinmed.2019-0271
We present the case of an 83-year-old woman, with known asthma, admitted with increasing dyspnoea, wheeze and a productive cough. In addition to maintenance inhaled therapy, the patient was also on long-term mirtazapine and furosemide. Following acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62caa6f0828fe9e64fd66ac793e11c4e
https://doi.org/10.7861/clinmed.2019-0271
https://doi.org/10.7861/clinmed.2019-0271
Autor:
Heather Green, Andrew Jones, D. Kenna, Jane F. Turton, Neil Woodford, Rowland J. Bright-Thomas
Publikováno v:
Epidemiol Infect
SummaryThis study aimed to determine prevalence of Ralstonia spp. in cystic fibrosis patients, look for any evidence of cross infection and to describe clinical outcomes for patients infected by Ralstonia spp. Prevalence of Ralstonia spp. was calcula
Autor:
Andrew Jones, R. Ashleigh, William G Flight, Peter J. Barry, S. Butterfield, Rowland J. Bright-Thomas
Publikováno v:
CardioVascular and Interventional Radiology. 40:1164-1168
Bronchial artery embolisation (BAE) is recommended for the treatment of massive haemoptysis in cystic fibrosis (CF), but there are no randomised controlled trials of this therapy and its role in sub-massive haemoptysis is unclear. This study aimed to